Four year experience of a dedicated connective tissue disorder pulmonary hypertension clinic

R. Lee, R. Martin, G. Coghlan, D. D‘Cruz (London, United Kingdom)

Source: Annual Congress 2009 - Pulmonary circulation II
Session: Pulmonary circulation II
Session type: Thematic Poster Session
Number: 3927
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Lee, R. Martin, G. Coghlan, D. D‘Cruz (London, United Kingdom). Four year experience of a dedicated connective tissue disorder pulmonary hypertension clinic. Eur Respir J 2009; 34: Suppl. 53, 3927

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Refining definitions of time to clinical worsening in connective tissue disease-associated pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010


1 year evolution of pulmonary hypertension in patients with connective tissue diseases and secondary antiphospholipid syndrome
Source: Eur Respir J 2004; 24: Suppl. 48, 280s
Year: 2004

Single centre experience of connective tissue disease (CTD) associated pulmonary arterial hypertension (PAH): Impact of a supra-regional screening programme
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010

Pulmonary involvement in patients diagnosed with inflammatory joint and connective disease in a multidisciplinary outpatient surgery
Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease
Year: 2010

Clinical and polysomnographic findings in patients with connective tissue disease and pulmonary hypertension
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008

Exercise training in pulmonary arterial hypertension associated with connective tissue diseases
Source: Annual Congress 2012 - Limiting factors in exercise
Year: 2012

Connective tissue disease associated with pulmonary arterial hypertension: management of a patient with severe haemodynamic impairment
Source: Eur Respir Rev 2014; 23: 505-509
Year: 2014


Pulmonary arterial hypertension associated with connective tissue disease: an integrated approach
Source: Annual Congress 2008 - Mastering pulmonary arterial hypertension: defined by evidence - enhanced by experience
Year: 2008

Pulmonary arterial hypertension in connective tissue diseases
Source: Eur Respir Mon 2012; 57: 42-57
Year: 2012


Ambrisentan therapy for patients with PAH associated with connective tissue disease (PAH-CTD): one year follow-up
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008


Veno-occlussive lesions and inflammation in pulmonary arterial hypertension associated with connective tissue diseases
Source: Annual Congress 2007 - Pulmonary hypertension in the clinic
Year: 2007


Social deprivation in Scottish populations with pulmonary hypertension secondary to connective tissue disease and chronic thromboembolic disease
Source: ERJ Open Res, 6 (4) 00297-2019; 10.1183/23120541.00297-2019
Year: 2020



A decade of activity in treating patients with pulmonary arterial hypertension in Timisoara center
Source: International Congress 2019 – Pulmonary hypertension: clinical
Year: 2019


Cardiac involvement in undifferentiated connective tissue disease at risk for systemic sclerosis. A tissue doppler imaging study
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016


Heritable connective tissue disorders as factor modifying asthma symptoms in pediatric patients
Source: Annual Congress 2012 - Asthma management
Year: 2012


Significance of connective tissue disease in a typical UK diffuse parenchymal lung disease clinic
Source: Annual Congress 2007 - Miscellaneous interstitial lung diseases related to systemic and other diseases
Year: 2007


Choosing pharmacotherapy for ILD in patients with connective tissue disease
Source: Breathe, 17 (4) 210114; 10.1183/20734735.0114-2021
Year: 2021



Acute effects of oxygen on pulmonary hemodynamic can help in differentiation of pulmonary hypertension at patients with connective tissue diseases
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015


Managing pregnancy in pulmonary hypertension using a multi-professional approach: a 16-year experience in a specialist referral centre
Source: International Congress 2017 – PAH and CTEPH
Year: 2017

Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment
Source: ERJ Open Res, 7 (3) 00854-2020; 10.1183/23120541.00854-2020
Year: 2021